These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 1295478

  • 1. A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E.
    Anticancer Res; 1992; 12(6B):2309-14. PubMed ID: 1295478
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
    Pasanen PA, Kauppinen R, Eskelinen M, Partanen K, Pikkarainen P, Alhava E.
    Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E.
    Br J Cancer; 1992 May; 65(5):731-4. PubMed ID: 1316775
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E.
    Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
    [Abstract] [Full Text] [Related]

  • 6. A prospective study on the value of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the diagnosis of unjaundiced cholestasis.
    Pasanen PA, Partanen K, Pikkarainen P, Alhava E, Pirinen A, Janatuinen E.
    In Vivo; 1994 Mar; 8(2):227-30. PubMed ID: 7919126
    [Abstract] [Full Text] [Related]

  • 7. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E.
    Br J Cancer; 1993 Apr; 67(4):852-5. PubMed ID: 8471445
    [Abstract] [Full Text] [Related]

  • 8. Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E.
    J Cancer Res Clin Oncol; 1994 Apr; 120(8):494-7. PubMed ID: 8207049
    [Abstract] [Full Text] [Related]

  • 9. [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].
    Clavé P, Boadas J, González-Carro P, Mora J, Pérez C, Martínez A, Roca M, Lluís F, Farré A.
    Gastroenterol Hepatol; 1999 Apr; 22(7):335-41. PubMed ID: 10535205
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of pancreatic cancer in patients with jaundice or cholestasis.
    Pasanen P, Partanen K, Pikkarainen P, Alhava E, Pirinen A, Janatuinen E.
    In Vivo; 1992 Apr; 6(3):297-301. PubMed ID: 1391698
    [Abstract] [Full Text] [Related]

  • 11. A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis.
    Pasanen PA, Partanen KP, Pikkarainen PH, Alhava EM, Janatuinen EK, Pirinen AE.
    Eur J Surg; 1993 Jan; 159(1):23-9. PubMed ID: 8095802
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E.
    Tumour Biol; 1994 Jan; 15(1):52-60. PubMed ID: 8146530
    [Abstract] [Full Text] [Related]

  • 13. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I.
    Anticancer Res; 1993 Mar; 13(5C):1883-7. PubMed ID: 8267397
    [Abstract] [Full Text] [Related]

  • 15. ERCP combined with tumor markers in differential diagnosis of pancreatic cancer and pseudotumor-like pancreatitis.
    Luo B, Peng F, Hong M, Su S, Fang C, Yang X, Xia G, Li B.
    J BUON; 2019 Mar; 24(4):1568-1573. PubMed ID: 31646810
    [Abstract] [Full Text] [Related]

  • 16. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H, Kaya M, Cengiz A.
    Hepatogastroenterology; 2003 Mar; 50(53):1669-74. PubMed ID: 14571813
    [Abstract] [Full Text] [Related]

  • 17. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
    Haglund C, Lundin J, Kuusela P, Roberts PJ.
    Br J Cancer; 1994 Sep; 70(3):487-92. PubMed ID: 8080735
    [Abstract] [Full Text] [Related]

  • 18. Serum CA 242: the search for a valid marker of pancreatic cancer.
    Ventrucci M, Ubalducci GM, Cipolla A, Panella MA, Ligabue A.
    Clin Chem Lab Med; 1998 Mar; 36(3):179-84. PubMed ID: 9589807
    [Abstract] [Full Text] [Related]

  • 19. Tumor markers in pancreatic cancer: a comparative clinical study between CEA, CA 19-9 and CA 50.
    Molina LM, Díez M, Cava MT, Maestro ML, Ortega MD, Mendíz JG, Prego A, De Diego JA, Balibrea JL.
    Int J Biol Markers; 1990 Mar; 5(3):127-32. PubMed ID: 2286776
    [Abstract] [Full Text] [Related]

  • 20. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
    Pezzilli R, Billi P, Plate L, Laudadio MA, Sprovieri G.
    Ital J Gastroenterol; 1995 Mar; 27(6):296-9. PubMed ID: 8562994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.